Patrick N. Pallier

Dr. Patrick N. Pallier

orcid

Research Focus & Metrics

Academic Career Length

30Years (1997-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 July 2007 in Journal of Neuroscience
Verified
Journal Article
Open access
PDF file
PPPatrick N. Pallier
Patrick N. Pallier
EMElizabeth S. Maywood
Elizabeth S. Maywood
ZZZhiguang Zheng
Zhiguang Zheng
JCJohanna E. Chesham
Johanna E. Chesham
AIAlexei N. Inyushkin
Alexei N. Inyushkin
AMA. Jennifer Morton
A. Jennifer Morton
Transgenic R6/2 mice carrying the Huntington's disease (HD) mutation show disrupted circadian rhythms that worsen as the disease progresses. By 15 weeks of age, their abnormal circadian behavior mirrors that seen in HD patients and is accompanied by dysregulated clock gene expression in the circadian pacemaker, the suprachiasmatic nucleus (SCN). We found, however, that the electrophysiological output of the SCN assayedin vitrowas normal. Furthermore, the endogenous rhythm of circadian gene expression, monitoredin vitroby luciferase imaging of organotypical SCN slices removed from mice with disintegrated behavioral rhythms, was also normal. We concluded that abnormal behavioral and molecular circadian rhythms observed in R6/2 micein vivoarise from dysfunction of brain circuitry afferent to the SCN, rather than from a primary deficiency within the pacemaker itself. Because circadian sleep disruption is deleterious to cognitive function, and cognitive decline is pronounced in R6/2 mice, we tested whether circadian and cognitive disturbances could be reversed by using a sedative drug to impose a daily cycle of sleep in R6/2 mice. Daily treatment with Alprazolam reversed the dysregulated expression ofPer2and alsoProk2, an output factor of the SCN that controls behavioral rhythms. It also markedly improved cognitive performance of R6/2 mice in a two-choice visual discrimination task. Together, our data show for the first time that treatments aimed at restoring circadian rhythms may not only slow the cognitive decline that is such a devastating feature of HD but may also improve other circadian gene-regulated functions that are impaired in this disease.

1 July 2004 in Behavioural Brain Research
Verified
Journal Article
Closed access
NSNicole C.A Schrijver
Nicole C.A Schrijver
PPPatrick N. Pallier
Patrick N. Pallier
VBVerity J Brown
Verity J Brown
HWHanno Würbel
Hanno Würbel

1 July 2009 in Brain Research
Verified
Journal Article
Closed access
PPPatrick N. Pallier
Patrick N. Pallier
AMA. Jennifer Morton
A. Jennifer Morton

1 March 2009 in Brain Research Bulletin
Verified
Journal Article
Closed access
PPPatrick N. Pallier
Patrick N. Pallier
CDCheney J.G. Drew
Cheney J.G. Drew
AMA. Jennifer Morton
A. Jennifer Morton

1 February 2014 in Neuroscience
Verified
Journal Article
Closed access
RWR.E. Ward
R.E. Ward
WHW. Huang
W. Huang
MKM. Kostusiak
M. Kostusiak
PPPatrick N. Pallier
Patrick N. Pallier
AMA.T. Michael-Titus
A.T. Michael-Titus
JPJ.V. Priestley
J.V. Priestley

25 August 2018 in Glia
Verified
Journal Article
Closed access
PDF file
SGSvetlana Gushchina
Svetlana Gushchina
GPGareth Pryce
Gareth Pryce
PYPing K. Yip
Ping K. Yip
DWDongsheng Wu
Dongsheng Wu
PPPatrick N. Pallier
Patrick N. Pallier
Xuenong BoXuenong Bo
Xuenong Bo